Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Sponsored Links
U.S. OKs Lupin generic of Pfizer nerve pain drug
(Reuters) - India's Lupin Ltd said it won U.S. approval for a generic version of Pfizer Inc's big-selling Lyrica nerve pain treatment.
A spokesman for Lupin said it has not yet launched its version of Lyrica, which is also known as pregabalin.
Lyrica tallied U.S. sales of about $1.8 billion for the year ended in March, Lupin said, citing data from IMS Health Inc.
(Reporting by Lewis Krauskopf; Editing by Gerald E. McCormick)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters